LEADER 01826nas  2200373 a 450 
001 9910696381603321
005 20080102131857.0
035   $a(CKB)5470000002377012
035   $a(OCoLC)186456595
035   $a(EXLCZ)995470000002377012
100   $a20080102a20039999  |a              
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aFY ... performance report to the President and the Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002$b[electronic resource]
210   $a[Rockville, Md.] $cFood and Drug Administration, Dept. of Health and Human Services
215   $aelectronic text, volumes $cHTML, digital, PDF file
300   $aDescription based on first issue; title from title screen (viewed on Dec. 5, 2007).
300   $aLatest issue consulted: 2006.
606   $aPharmaceutical industry$zUnited States$vPeriodicals
606   $aDrugs$xLaw and legislation$zUnited States$vPeriodicals
606   $aDrugs$zUnited States$xTesting$vPeriodicals
615  0$aPharmaceutical industry
615  0$aDrugs$xLaw and legislation
615  0$aDrugs$xTesting
712 02$aUnited States.$bFood and Drug Administration.
801  0$bGPO
801  1$bGPO
906   $aJOURNAL
912   $a9910696381603321
996   $aFY ... performance report to the President and the Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 and the Public Health Security and Bioterrorism Preparedness and Response Act of 2002$93449592
997   $aUNINA